J
Joseph S. Bresee
Researcher at Centers for Disease Control and Prevention
Publications - 261
Citations - 35039
Joseph S. Bresee is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Rotavirus & Vaccination. The author has an hindex of 78, co-authored 255 publications receiving 32225 citations. Previous affiliations of Joseph S. Bresee include National Center for Immunization and Respiratory Diseases.
Papers
More filters
Journal ArticleDOI
Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France).
Bradford D. Gessner,W. Abdullah Brooks,W. Abdullah Brooks,Kathleen M. Neuzil,Guy Vernet,Rick A. Bright,John S. Tam,Joseph S. Bresee,Arnold S. Monto +8 more
TL;DR: A vaccine probe approach was used to estimate vaccine preventable disease incidence (VPDI) for Streptococcus pneumoniae and Haemophilus influenzae type b and found that maternal influenza immunization can reduce acute respiratory infection in the infant during this vulnerable period.
Journal ArticleDOI
National pandemic influenza preparedness planning.
Eduardo Azziz-Baumgartner,Nicole M. Smith,Raquel González-Alvarez,Sharon Daves,Marcelle Layton,Nivaldo Linares,Nicole Richardson-Smith,Joseph S. Bresee,Anthony W. Mounts +8 more
TL;DR: This study discusses the process of drafting a pandemic influenza preparedness plan for developing countries that conforms to the International Health Regulations of 2005 and recommendations of the World Health Organization.
Journal Article
Update: influenza activity - United States, September 28, 2008-January 31, 2009.
Lynnette Brammer,Scott Epperson,Lenee Blanton,R. Dhara,Teresa R. Wallis,Lyn Finelli,Anthony E. Fiore,L. Gubavera,Joseph S. Bresee,Alexander Klimov,Nancy J. Cox,Carrie Reed +11 more
TL;DR: From September 28, 2008, to January 31, 2009, influenza activity remained low in the United States but began to increase at the end of January, with high levels of adamantane resistance among influenza A (H3N2) viruses.
Journal ArticleDOI
The Burden of Hospitalizations and Clinic Visits for Rotavirus Disease in Children Aged <5 Years in the Philippines
Celia C. Carlos,Marianette T. Inobaya,Joseph S. Bresee,Marietta L Lagrada,Agnettah M Olorosa,Carl D. Kirkwood,Marc-Alain Widdowson +6 more
TL;DR: The burden of rotav virus gastroenteritis in the Philippines is high and is predominantly caused by strains against which current vaccines have shown good efficacy, suggesting that routine immunization will have a large impact on rotavirus disease burden.
Journal ArticleDOI
Lack of SARS Transmission and U.S. SARS Case-Patient
Angela J. Peck,E. Claire Newbern,Daniel R. Feikin,Elmira T. Isakbaeva,Benjamin J. Park,Jason T. Fehr,Ashley C. LaMonte,Thong P. Le,Terry L. Burger,Luther V. Rhodes,Andre Weltman,Dean D. Erdman,Thomas G. Ksiazek,Jairam R. Lingappa,Marc-Alain Widdowson,Nino Khetsuriani,L. Clifford McDonald,Stephan S. Monroe,Suxiang Tong,James A. Comer,Daniel B. Jernigan,Matthew J. Kuehnert,Joseph S. Bresee,Sara A. Lowther,Larry J. Anderson,Mary Theresa Temarantz,John P. Bart,William S. Miller,Mary Jo Lampart,Carol Yozviak,Shana Stites,Susan Oliver,Debra Wilson,Carol Guanowsky,Beverly Wasko,Corwin Robertson,Dianne Krolikowski,Jeff Bomboy,Reynaldo C. Guerra +38 more
TL;DR: L Laboratory evaluation of clinical specimens showed no evidence of transmission of SARS-associated coronavirus (SARS-CoV) infection to any close contact of this patient, and this investigation documents that, under certain circumstances, SARS -CoV is not readily transmitted to close contacts, despite ample unprotected exposures.